Tanzeel Khan, Rashid Waseem, Zainy Zehra, Ayesha Aiman, Priyanka Bhardwaj, Jaoud Ansari, Md. Imtaiyaz Hassan & Asimul Islam. (2022) Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches. Pharmaceutics 14:12, pages 2657.
Crossref
Ardhendu Kumar Mandal. (2022) Mitochondrial targeting of potent nanoparticulated drugs in combating diseases. Journal of Biomaterials Applications 37:4, pages 614-633.
Crossref
Jiarun Lin, Kylie Yang & Elizabeth J. New. 2022. Molecular Fluorescent Sensors for Cellular Studies. Molecular Fluorescent Sensors for Cellular Studies
63
81
.
Yingying Shi, Zhenyu Luo & Jian You. (2022) Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria. WIREs Nanomedicine and Nanobiotechnology 14:5.
Crossref
Kuizhi Chen, Jialin Hou, Bingcheng Huang, Shuanghuang Xiao, Xia Li, Hong Sun & Yiru Peng. (2022) Bromopropylate Imidazoliumyl Substituted Silicon Phthalocyanine for Mitochondria-Targeting, Two-Photon Imaging Guided in Vitro Photodynamic Therapy. Frontiers in Pharmacology 13.
Crossref
Wendy Wei Gan, Lai Wah Chan, Wenji Li & Tin Wui Wong. (2022) Critical clinical gaps in cancer precision nanomedicine development. Journal of Controlled Release 345, pages 811-818.
Crossref
Vijay Sharma & Kamla Pathak. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders
411
423
.
Jindriska Leischner Fialova, Martina Raudenska, Milan Jakubek, Zdenek Kejik, Pavel Martasek, Petr Babula, Adam Matkowski, Petr Filipensky & Michal Masarik. (2021) Novel Mitochondria-targeted Drugs for Cancer Therapy. Mini-Reviews in Medicinal Chemistry 21:7, pages 816-832.
Crossref
Christian Bailly. (2021) Medicinal applications and molecular targets of dequalinium chloride. Biochemical Pharmacology 186, pages 114467.
Crossref
Si Si Liew, Xiaofei Qin, Jia Zhou, Lin Li, Wei Huang & Shao Q. Yao. (2020) Smart Design of Nanomaterials for Mitochondria‐Targeted Nanotherapeutics. Angewandte Chemie International Edition 60:5, pages 2232-2256.
Crossref
Si Si Liew, Xiaofei Qin, Jia Zhou, Lin Li, Wei Huang & Shao Q. Yao. (2020) Intelligentes Design von Nanomaterialien für Mitochondrien‐gerichtete Nanotherapeutika. Angewandte Chemie 133:5, pages 2260-2286.
Crossref
Harish Padh, Snehal Shenoy, Shreya Thakkar & Manju Misra. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics
263
289
.
Amaraporn Wongrakpanich, Jiraphong Suksiriworapong, Sean M. Geary, Phawanan Sawangchan, Janjira Intra, Uracha Ruktanonchai & Aliasger K. Salem. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics
291
310
.
Volkmar Weissig, Maria Lozoya, Nusem Yu & Gerard G. M. D’Souza. 2021. Mitochondrial Medicine. Mitochondrial Medicine
13
25
.
Saravana Babu Chidambaram, Bipul Ray, Abid Bhat, Arehally Marappa Mahalakshmi, Tuladhar Sunanda, Padamati Jagadeeswari, Mysore Prakash Gowrav, Ramesh Chandra & Meena Kishore Sakharkar. 2020. Delivery of Drugs. Delivery of Drugs
97
117
.
Sagar Dhoble, Shrikant Dhage, Sreeranjini Pulakkat & Vandana B. Patravale. 2019. Novel Drug Delivery Technologies. Novel Drug Delivery Technologies
403
431
.
Ana L. Silva, Liane I.F. Moura, Bárbara Carreira, João Conniot, Ana I. Matos, Carina Peres, Vanessa Sainz, Liana C. Silva, Rogério S. Gaspar & Helena F. Florindo. 2018. Biomedical Applications of Functionalized Nanomaterials. Biomedical Applications of Functionalized Nanomaterials
399
448
.
Zhenjie Wang, Weiling Guo, Xiao Kuang, Shanshan Hou & Hongzhuo Liu. (2017) Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective. Asian Journal of Pharmaceutical Sciences 12:6, pages 498-508.
Crossref
Laurent Gaté, Frédéric Cosnier & Flemming R. Cassee. 2017. Biomedical Application of Nanoparticles. Biomedical Application of Nanoparticles
163
188
.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez & Balaraman Kalyanaraman. (2017) Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chemical Reviews 117:15, pages 10043-10120.
Crossref
Wei Zhou, Hui Yu, Liu-Jie Zhang, Bo Wu, Cai-Xia Wang, Qian Wang, Kai Deng, Ren-Xi Zhuo & Shi-Wen Huang. (2017) Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy. Nanoscale 9:43, pages 17044-17053.
Crossref
Animikh Ray & Ashim K. Mitra. 2017. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices
169
188
.
. 2016. Bio-Targets and Drug Delivery Approaches. Bio-Targets and Drug Delivery Approaches
259
289
.
Gerard D’Souza, Paul Nguyen & Volkmar Weissig. 2016. Drug Delivery Across Physiological Barriers. Drug Delivery Across Physiological Barriers
367
389
.
Ru Wen, Bhabatosh Banik, Rakesh K. Pathak, Anil Kumar, Nagesh Kolishetti & Shanta Dhar. (2016) Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Advanced Drug Delivery Reviews 99, pages 52-69.
Crossref
Bhabatosh Banik, Brett W. Askins & Shanta Dhar. (2016) Mito-magneto: a tool for nanoparticle mediated mitochondria isolation. Nanoscale 8:47, pages 19581-19591.
Crossref
Diana Guzman-Villanueva & Volkmar Weissig. 2017. Pharmacology of Mitochondria. Pharmacology of Mitochondria
423
438
.
Bhuvaneshwar Vaidya, Samit Shah & Vivek Gupta. 2015. Mitochondria in Liver Disease. Mitochondria in Liver Disease
169
192
.
Josephine Modica-Napolitano & Volkmar Weissig. (2015) Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents. International Journal of Molecular Sciences 16:8, pages 17394-17421.
Crossref
Nadezda ApostolovaVictor M. Victor. (2015) Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications. Antioxidants & Redox Signaling 22:8, pages 686-729.
Crossref
Shengpeng Wang, Jiange Qiu, Zhi Shi, Yitao Wang & Meiwan Chen. (2015) Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer. Biotechnology Advances 33:1, pages 224-241.
Crossref
Udita Agrawal, Rajeev Sharma & Suresh P. Vyas. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
241
270
.
Volkmar Weissig. 2015. Mitochondrial Medicine. Mitochondrial Medicine
1
11
.
SIA LEE YOONG & GIORGIA PASTORIN. (2015) NANODELIVERY SYSTEM FOR MITOCHONDRIAL TARGETING. COSMOS 10:01, pages 39-51.
Crossref
Amaraporn Wongrakpanich, Sean M Geary, Mei-ling A Joiner, Mark E Anderson & Aliasger K Salem. (2014) Mitochondria-targeting particles. Nanomedicine 9:16, pages 2531-2543.
Crossref
Špela Zupančič, Petra Kocbek, M. Gulrez Zariwala, Derek Renshaw, Mine Orlu Gul, Zeeneh Elsaid, Kevin M. G. Taylor & Satyanarayana Somavarapu. (2014) Design and Development of Novel Mitochondrial Targeted Nanocarriers, DQAsomes for Curcumin Inhalation. Molecular Pharmaceutics 11:7, pages 2334-2345.
Crossref
Richard W Horobin. (2014)
Where do dyes go inside living cells? Predicting uptake, intracellular localisation, and accumulation using
QSAR
models
. Coloration Technology 130:3, pages 155-173.
Crossref
Sutapa Barua & Samir Mitragotri. (2014) Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today 9:2, pages 223-243.
Crossref
Lucia Biasutto, Ildikò Szabò & Mario Zoratti. 2014. Mitochondria: The Anti- cancer Target for the Third Millennium. Mitochondria: The Anti- cancer Target for the Third Millennium
211
264
.
Melani A. Solomon, Anee A. Shah & Gerard G.M. D'Souza. (2013) In Vitro assessment of the utility of stearyl triphenyl phosphonium modified liposomes in overcoming the resistance of ovarian carcinoma Ovcar-3 cells to paclitaxel. Mitochondrion 13:5, pages 464-472.
Crossref
Yuma Yamada & Hideyoshi Harashima. (2013) Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier. Mitochondrion 13:5, pages 526-532.
Crossref
Jan Gruber, Sheng Fong, Ce-Belle Chen, Sialee Yoong, Giorgia Pastorin, Sebastian Schaffer, Irwin Cheah & Barry Halliwell. (2013) Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnology Advances 31:5, pages 563-592.
Crossref
Rodney Siwale, Fred Meadows, Vicky V Mody & Samit Shah. (2013)
Formulation and drug-content assay of microencapsulated antisense oligonucleotide to NF-
κ
B using ATR-FTIR
. Advances in Natural Sciences: Nanoscience and Nanotechnology 4:3, pages 035002.
Crossref
Richard W. Horobin, Juan C. Stockert & F. Rashid-Doubell. (2013) Uptake and localisation of small-molecule fluorescent probes in living cells: a critical appraisal of QSAR models and a case study concerning probes for DNA and RNA. Histochemistry and Cell Biology 139:5, pages 623-637.
Crossref
Juan C. Stockert, Alfonso Blázquez-Castro, Magdalena Cañete, Richard W. Horobin & Ángeles Villanueva. (2012) MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochemica 114:8, pages 785-796.
Crossref
Dominik Kölmel, Daniel Fürniss, Steven Susanto, Andrea Lauer, Clemens Grabher, Stefan Bräse & Ute Schepers. (2012) Cell Penetrating Peptoids (CPPos): Synthesis of a Small Combinatorial Library by Using IRORI MiniKans. Pharmaceuticals 5:12, pages 1265-1281.
Crossref
K Thompson, P Dockery & RW Horobin. (2012) Predicting and avoiding subcellular compartmentalization artifacts arising from acetoxymethyl ester calcium imaging probes. The case of fluo-3 AM and a general account of the phenomenon including a problem avoidance chart. Biotechnic & Histochemistry, pages 1-16.
Crossref
Shelley A. Durazo & Uday B. Kompella. (2012) Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion 12:2, pages 190-201.
Crossref
Alexander V. LyubimovMeihua Rose Feng, Nan Zheng, Xinyuan Zhang, Yea Min Huh & Jing‐yu Yu. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Volkmar Weissig. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases
131
155
.
Volkmar Weissig. (2011) From Serendipity to Mitochondria-Targeted Nanocarriers. Pharmaceutical Research 28:11, pages 2657-2668.
Crossref
Netanel Kolevzon, Uriel Kuflik, Miriam Shmuel, Sandrine Benhamron, Israel Ringel & Eylon Yavin. (2011) Multiple Triphenylphosphonium Cations as a Platform for the Delivery of a Pro-Apoptotic Peptide. Pharmaceutical Research 28:11, pages 2780-2789.
Crossref
Ana I. García-Pérez, Eva Galeano, Elena Nieto & Pilar Sancho. (2011) Dequalinium induces human leukemia cell death by affecting the redox balance. Leukemia Research 35:10, pages 1395-1401.
Crossref
Xiao-Xing Wang, Yang-Bing Li, Hong-Juan Yao, Rui-Jun Ju, Yan Zhang, Ruo-Jing Li, Yang Yu, Liang Zhang & Wan-Liang Lu. (2011) The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 32:24, pages 5673-5687.
Crossref
A. Rovini, A. Savry, D. Braguer & M. Carré. (2011) Microtubule-targeted agents: When mitochondria become essential to chemotherapy. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807:6, pages 679-688.
Crossref
Gerard G.M. D'Souza, Mayura A Wagle, Vaibhav Saxena & Anee Shah. (2011) Approaches for targeting mitochondria in cancer therapy. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807:6, pages 689-696.
Crossref
M. Weyland, F. Manero, A. Paillard, D. Grée, G. Viault, D. Jarnet, P. Menei, P. Juin, I. Chourpa, J.-P. Benoit, R. Grée & E. Garcion. (2011) Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. Journal of Controlled Release 151:1, pages 74-82.
Crossref
Melani Solomon & Gerard G. M. D’Souza. 2011. Intracellular Delivery. Intracellular Delivery
57
72
.
Volkmar Weissig & Gerard G. M. D'Souza. 2010. Organelle-Specific Pharmaceutical Nanotechnology. Organelle-Specific Pharmaceutical Nanotechnology
385
401
.
Richard W. Horobin. 2010. Organelle-Specific Pharmaceutical Nanotechnology. Organelle-Specific Pharmaceutical Nanotechnology
193
206
.
Gerard G. M. D'Souza & Volkmar Weissig. 2010. Organelle-Specific Pharmaceutical Nanotechnology. Organelle-Specific Pharmaceutical Nanotechnology
1
13
.
Kevin Y. Miyashiro, Thomas J. Bell, Jai-Yoon Sul & James Eberwine. (2009) Subcellular neuropharmacology: the importance of intracellular targeting. Trends in Pharmacological Sciences 30:4, pages 203-211.
Crossref
Nancy J. Woolf, Avner Priel & Jack A. TuszynskiNancy J. Woolf, Avner Priel & Jack A. Tuszynski. 2010. Nanoneuroscience. Nanoneuroscience
177
226
.
Nancy J. Woolf, Avner Priel & Jack A. TuszynskiNancy J. Woolf, Avner Priel & Jack A. Tuszynski. 2010. Nanoneuroscience. Nanoneuroscience
129
176
.